Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Secondly, potential drug-supplement interactions must be considered, especially in women undergoing pharmacological treatments for PCOS or comorbidities
In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Eshkevari, Ladan, et al
It has attracted scientific interest because of its possible protective and healing effects in preclinical models
US$ 26.89
US$ 25.70
US$ 24.13
US$ 23.05
US$ 21.09
